Reduce Lantus by 10-20% immediately when hypoglycemia occurs without a clear cause
For a patient on Lantus 25 units experiencing hypoglycemic episodes, decrease the dose to 20-22.5 units (a 10-20% reduction) and investigate the underlying cause. This recommendation comes directly from the 2025 American Diabetes Association Standards of Care 1 and is reinforced by the FDA prescribing information for Lantus 2.
Immediate Dose Adjustment Algorithm
When hypoglycemia occurs on basal insulin:
First, determine if there's a clear cause:
- Missed meals or reduced carbohydrate intake
- Increased physical activity
- Alcohol consumption
- Changes in other medications
- Acute illness affecting oral intake
- Injection site issues (lipodystrophy, incorrect rotation)
If NO clear reversible cause is identified:
- Reduce Lantus dose by 10-20% 1
- For 25 units: decrease to 20-22.5 units
- This reduction should be implemented immediately, not gradually
If a clear cause IS identified:
- Address the specific cause
- May still require temporary dose reduction depending on severity and frequency of hypoglycemia
Critical Monitoring After Dose Adjustment
- Check fasting blood glucose daily for at least 3-7 days after dose reduction
- Monitor for any hypoglycemic episodes (blood glucose <70 mg/dL)
- Assess timing of hypoglycemia (nocturnal vs daytime) to confirm it's related to basal insulin
- Prescribe glucagon for emergent hypoglycemia if not already available 1
Retitration Strategy
Once hypoglycemia is controlled with the reduced dose:
- Wait 3-7 days to assess stability
- If fasting glucose remains above target (typically >130 mg/dL) without hypoglycemia, consider gradual uptitration
- Increase by 2 units every 3 days toward fasting plasma glucose goal 1
- Target fasting glucose typically 80-130 mg/dL (individualize based on patient factors)
Important Caveats
Common pitfalls to avoid:
- Don't wait for "patterns" - even a single unexplained severe hypoglycemic episode warrants dose reduction
- Don't assume the dose is "too low to cause problems" - 25 units can absolutely cause hypoglycemia depending on the patient's insulin sensitivity, renal function, and other factors
- Verify injection technique - patients may inadvertently inject intramuscularly (especially in deltoid or lean patients), causing faster absorption and hypoglycemia
- Check for lipodystrophy - injection into lipohypertrophic areas causes erratic absorption 2
Consider these additional factors:
- Renal impairment reduces insulin clearance and increases hypoglycemia risk - may need more aggressive dose reduction (20% or more)
- Elderly patients have higher hypoglycemia risk and may benefit from less stringent glycemic targets
- If on sulfonylureas or glinides - consider reducing or discontinuing these medications rather than (or in addition to) reducing insulin, as they significantly increase hypoglycemia risk
- Timing of administration - ensure Lantus is given at the same time daily; erratic timing can contribute to hypoglycemia 2
The evidence strongly supports that a 10-20% dose reduction effectively reduces hypoglycemia risk while maintaining reasonable glycemic control 1, 2. Real-world data confirms that even a 20% reduction when switching between insulin formulations significantly reduces hypoglycemia incidence (from 24.7% to 11.9%) 3, supporting the safety and efficacy of this approach.